Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63 (Q36708676)

From Wikidata

Jump to navigation Jump to search

scientific article published on December 1993

Language	Label	Description	Also known as
English	Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63	scientific article published on December 1993

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Effective immunization against cutaneous leishmaniasis with recombinant bacille Calmette-Guérin expressing the Leishmania surface proteinase gp63 (English)

1 reference

Europe PubMed Central

15 August 2017

0 references

cutaneous leishmaniasis

1 reference

based on heuristic

inferred from title

author name string

N D Connell

1

1 reference

Europe PubMed Central

15 August 2017

E Medina-Acosta

2

1 reference

Europe PubMed Central

15 August 2017

W R McMaster

3

1 reference

Europe PubMed Central

15 August 2017

B R Bloom

4

1 reference

Europe PubMed Central

15 August 2017

D G Russell

5

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

1 December 1993

1 reference

Europe PubMed Central

15 August 2017

Proceedings of the National Academy of Sciences of the United States of America

1 reference

Europe PubMed Central

15 August 2017

90

1 reference

Europe PubMed Central

15 August 2017

24

1 reference

Europe PubMed Central

15 August 2017

11473-11477

1 reference

Europe PubMed Central

15 August 2017

Pure protein from Leishmania donovani protects mice against both cutaneous and visceral leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Evolution and expression of the Leishmania surface proteinase (gp63) gene locus.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Mycobacterium bovis BCG-induced protection against cutaneous and systemic Leishmania major infections of mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

T-cell responses and immunity to experimental infection with leishmania major

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Functional heterogeneity of CD4+ T cells in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Development of BCG as a recombinant vaccine vehicle.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Molecular cloning and characterization of the immunologically protective surface glycoprotein GP46/M-2 of Leishmania amazonensis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

The interaction between CD8+ cytotoxic T cells and Leishmania-infected macrophages

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

New use of BCG for recombinant vaccines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Induction of Th1 and Th2 CD4+ subsets during murine Leishmania major infection

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Modification of GP63 genes from diverse species of Leishmania for expression of recombinant protein at high levels in Escherichia coli

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Immunoprotective Leishmania major synthetic T cell epitopes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Induction, regulation and function of T-cell subsets in leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

30 September 2017

Structurally distinct genes for the surface protease of Leishmania mexicana are developmentally regulated.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

The promastigote surface protease (gp63) of Leishmania is expressed but differentially processed and localized in the amastigote stage

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

The major surface glycoprotein (GP63) is present in both life stages of Leishmania

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

Developmental modification of the lipophosphoglycan from Leishmania major promastigotes during metacyclogenesis.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

Oral Salmonella typhimurium (AroA-) vaccine expressing a major leishmanial surface protein (gp63) preferentially induces T helper 1 cells and protective immunity against leishmaniasis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

Reconstitution of Leishmania immunity in severe combined immunodeficient mice using Th1- and Th2-like cell lines

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

Leishmania major: differential regulation of the surface metalloprotease in amastigote and promastigote stages.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

28 June 2018

Expression of lipophosphoglycan, high-molecular weight phosphoglycan and glycoprotein 63 in promastigotes and amastigotes of Leishmania mexicana

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=48006

5 September 2018

Cytokine control of Leishmania infection in the BALB/c mouse: enhancement and inhibition of parasite growth by local administration of IL-2 or IL-4 is species and time dependent

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Intracellular trafficking and the parasitophorous vacuole of Leishmania mexicana-infected macrophages

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Mapping human T cell epitopes in leishmania gp63. Identification of cross-reactive and species-specific epitopes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The lysosomal gp63-related protein in Leishmania mexicana amastigotes is a soluble metalloproteinase with an acidic pH optimum

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of T cells in the unusual cutaneous responses to Leishmania in BALB/c mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy versus chemotherapy in localised cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effective immunization against cutaneous leishmaniasis with defined membrane antigens reconstituted into liposomes

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Genes encoding the major surface glycoprotein in Leishmania are tandemly linked at a single chromosomal locus and are constitutively transcribed

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Immunotherapy of localized, intermediate, and diffuse forms of American cutaneous leishmaniasis

1 reference

https://pubmed.ncbi.nlm.nih.gov/8265576

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1073/PNAS.90.24.11473

1 reference

Europe PubMed Central

15 August 2017

1993PNAS...9011473C

0 references

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36708676&oldid=1549812774"